The first indoleamine-2,3-dioxygenase-1 (IDO1) inhibitors containing carborane

Christopher J.D. Austin, Jan Kahlert, Fatiah Issa, John H. Reed, Jason R. Smith, Joseph A. Ioppolo, Jennifer A. Ong, Joanne F. Jamie, David Hibbs, Louis M. Rendina

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Abstract

Indoleamine-2,3-dioxygenase-1 (IDO1) is a critical immunoregulatory enzyme responsible for the metabolism of tryptophan during inflammation and disease. Based upon a pyranonaphthoquinone framework, the first examples of indoleamine-2,3-dioxygenase-1 (IDO1) inhibitors containing a carborane cage are reported. The novel closo-1,2-carboranyl-N-pyranonaphthoquinone derivatives display low μM binding affinity for the human recombinant enzyme, with IC50 values ranging from 0.78 to 1.77 μM.

Original languageEnglish
Pages (from-to)10719-10724
Number of pages6
JournalDalton Transactions
Volume43
Issue number28
DOIs
Publication statusPublished - 28 Jul 2014
Externally publishedYes

Fingerprint

Dive into the research topics of 'The first indoleamine-2,3-dioxygenase-1 (IDO1) inhibitors containing carborane'. Together they form a unique fingerprint.

Cite this